Liquid biopsies offer huge potential, not just as non-invasive diagnostic tests, but also for guiding treatment and monitoring patient care. Oncologists at the Dana-Farber Cancer Institute, Boston, Massachusetts, are using digital PCR to help inform key treatment decisions. Se...
|